Fatty Liver Breakthrough: Vitamin B3 Shows Promise

Approximately 30 percent of the global population is affected by metabolic-associated fatty liver disease (MASLD), a condition that previously lacked targeted treatments. In a groundbreaking discovery, researchers have identified a genetic factor that exacerbates the disease, and remarkably, the FDA-approved drug that most effectively targets this factor is vitamin B3. A collaborative research team led ...